---
category: news
title: "AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer"
excerpt: "Artificial intelligence was used to develop a predictive biomarker to identify patients with intermediate-risk prostate cancer who would benefit from adding androgen deprivation therapy to radiotherapy."
publishedDateTime: 2023-07-06T13:00:00Z
originalUrl: "https://www.curetoday.com/view/ai-may-predict-benefit-with-hormone-therapy-plus-radiotherapy-in-prostate-cancer"
webUrl: "https://www.curetoday.com/view/ai-may-predict-benefit-with-hormone-therapy-plus-radiotherapy-in-prostate-cancer"
type: article
quality: 29
heat: -1
published: false

provider:
  name: Cure Today
  domain: curetoday.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Predictive AI Biomarker for ADT Benefit in Prostate Cancer Identified"
    excerpt: "New AI biomarker predicts the benefit of short-term androgen deprivation therapy (ADT) in men with predominantly intermediate-risk prostate cancer."
    publishedDateTime: 2023-07-10T13:34:00Z
    webUrl: "https://healthitanalytics.com/news/predictive-ai-biomarker-for-adt-benefit-in-prostate-cancer-identified"
    type: article
    provider:
      name: Analytics
      domain: healthitanalytics.com
    quality: 39
    images:
      - url: "https://healthitanalytics.com/images/site/article_headers/_normal/2022-03-18-GettyImages-1255213318.jpg"
        width: 690
        height: 400
        isCached: true
  - title: "Novel AI Model Predicts ADT Benefit in Patients With Prostate Cancer"
    excerpt: "A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence."
    publishedDateTime: 2023-07-06T19:39:00Z
    webUrl: "https://www.ajmc.com/view/novel-ai-model-predicts-adt-benefit-in-patients-with-prostate-cancer"
    type: article
    provider:
      name: The American Journal of Managed Care
      domain: ajmc.com
    quality: 19

secured: "DV6LyD4I0ERhmOhQABSHHeLZ4/I7iA1wTBEfV0aJoXEqvUGhS3ENgg6ZmIGxt5XbvmqU2t2SnwcBXbhdSjKfiS7a/iQziStiriOi/x8ByWBvfqkSm13OUw7jOfxe4GE9ufAq2fIbE/M8Eo7M5x2t5hj+mFOhCg49xUB0mouhEWwQ3oRRvkmYO5pC79pSaj8unNTyugxWRTDH+eW8a9uXb+rIQDb4qLfR53/5wS+3gif0R/H8yZZIccJdy1MkrrDPe0vNNk4Hq9UNyIEmzTMIXm8U59yEGVy1vLI61i30QJreesuCyhOcao3WYBdkp0NO6ECaZdlq0Kde4jSelCwE6HOpE7u/N/Utz+ep9jimv6oG47dM7lKRWger7D8mPmj7EWvMl1n1mWz5pwxQuRUtjUB/RUIE2p18CntCxS+WnfAp+TfEuoSA3WLgclE4gGCSS+ll6MCiQcksaWAOFHZ27RDbrd3rlctS2bOR+dd1+dCe2LZxATQgXJtu1tZAwyAUrdJs6N4yITuJuY2IcXqpnA==;LaayE7fSk7hnshdie4gwSg=="
---

